GlassScriptPhysician profile
Shana W Rose
NPI 1508020645
$4,801.75
in general payments reported to CMS, 2019-2025
25 companies · $768 in 2025
The $768 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $231 · 2021: $828 · 2022: $661 · 2023: $963 · 2024: $791 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,520.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,660.45 | 2019-2025 | Hydrus Microstent, Clareon Panoptix Pro, Argos |
| Bausch & Lomb Americas INC. | $492.25 | 2023-2025 | Envista Mx60 Iol, Stellaris, Envista Envy Iol |
| Abbvie INC. | $433.14 | 2022-2024 | Durysta, Lumigan, Alphagan P |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $376.03 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $375.36 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Allergan, INC. | $189.18 | 2019-2022 | |
| Oyster Point Pharma, INC. | $141.74 | 2023-2024 | Tyrvaya |
| Rxsight INC | $137.93 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $135.51 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $128.31 | 2019-2025 | |
| Eyevance Pharmaceuticals LLC | $122.27 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $110.34 | 2021 | |
| Kala Pharmaceuticals, INC. | $85.67 | 2019-2022 | |
| Biotissue Holdings INC. | $61.01 | 2019-2020 | |
| Amgen INC. | $54.20 | 2024 | Tepezza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $48.28 | 2023 | Lumera 700 |
| Dompe US, INC. | $42.83 | 2020-2025 | Oxervate |
| Sight Sciences, INC. | $34.88 | 2024 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $32.86 | 2019-2021 | |
| Harrow Eye, LLC | $30.42 | 2024 | Vevye |
| Shire North American Group INC | $28.28 | 2019 | |
| New World Medical,INC. | $23.32 | 2021 | |
| Glaukos Corporation | $23.27 | 2019 | |
| Thea Pharma INC. | $20.77 | 2025 | Iyuzeh |
| Rayner Intraocular Lenses Limited | $13.45 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shana Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.